UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Percutaneous Coronary Interventions for Chronic Total Occlusions: As the Technology Expands, Our Responsibilities Increase

Circulation (New York, N.Y.), 2017-04, Vol.135 (15), p.1385-1387

Bass, Theodore A

2017

Volltextzugriff (PDF)

Platelet Inhibition With Cangrelor and Crushed Ticagrelor in Patients With ST-Segment–Elevation Myocardial Infarction Undergoing Primary Percutaneous Coronary Intervention: Results of the CANTIC Study

Circulation (New York, N.Y.), 2019-04, Vol.139 (14), p.1661-1670

2019

Volltextzugriff (PDF)

Variability in individual responsiveness to clopidogrel : Clinical implications, management, and future perspectives

Journal of the American College of Cardiology, 2007-04, Vol.49 (14), p.1505-1516

2007

Volltextzugriff (PDF)

High-Risk Percutaneous Coronary Interventions in Modern Day Clinical Practice: Current Concepts and Challenges

Circulation. Cardiovascular interventions, 2015-12, Vol.8 (12), p.e003405-e003405

Bass, Theodore A

2015

Volltextzugriff (PDF)

Percutaneous Coronary Intervention Versus Coronary Artery Bypass Graft Surgery in Left Main Coronary Artery Disease: A Meta-Analysis of Randomized Clinical Data

Journal of the American College of Cardiology, 2011-09, Vol.58 (14), p.1426-1432

2011

Volltextzugriff (PDF)

Pharmacodynamic Comparison of Prasugrel Versus Ticagrelor in Patients With Type 2 Diabetes Mellitus and Coronary Artery Disease: The OPTIMUS (Optimizing Antiplatelet Therapy in Diabetes Mellitus)-4 Study

Circulation (New York, N.Y.), 2016-09, Vol.134 (11), p.780-792

2016

Volltextzugriff (PDF)

The Challenges Involving Assessing Percutaneous Coronary Intervention Outcomes in Safety-Net Hospitals

JACC. Cardiovascular interventions, 2017-08, Vol.10 (15), p.1486-1488

Bass, Theodore A.

2017

Volltextzugriff (PDF)

Crushed Prasugrel Tablets in Patients With STEMI Undergoing Primary Percutaneous Coronary Intervention: The CRUSH Study

Journal of the American College of Cardiology, 2016-05, Vol.67 (17), p.1994-2004

2016

Volltextzugriff (PDF)

Impact of Stent Deployment Procedural Factors on Long-Term Effectiveness and Safety of Sirolimus-Eluting Stents (Final Results of the Multicenter Prospective STLLR Trial)

The American journal of cardiology, 2008-06, Vol.101 (12), p.1704-1711

2008

Volltextzugriff (PDF)

Impact of Chronic Kidney Disease on Platelet Function Profiles in Diabetes Mellitus Patients With Coronary Artery Disease Taking Dual Antiplatelet Therapy

Journal of the American College of Cardiology, 2010-03, Vol.55 (11), p.1139-1146

2010

Volltextzugriff (PDF)

Long-Term Outcomes in Patients Undergoing Coronary Stenting on Dual Oral Antiplatelet Treatment Requiring Oral Anticoagulant Therapy

The American journal of cardiology, 2008-12, Vol.102 (12), p.1618-1623

2008

Volltextzugriff (PDF)

Impact of Platelet Reactivity on Cardiovascular Outcomes in Patients With Type 2 Diabetes Mellitus and Coronary Artery Disease

Journal of the American College of Cardiology, 2007-10, Vol.50 (16), p.1541-1547

2007

Volltextzugriff (PDF)

Crushed Prasugrel Tablets in Patients With STEMI Undergoing Primary Percutaneous Coronary Intervention

Journal of the American College of Cardiology, 2016-05, Vol.67 (17), p.1994-2004

2016

Volltextzugriff (PDF)

Pharmacodynamic Effects of Switching From Ticagrelor to Clopidogrel in Patients With Coronary Artery Disease: Results of the SWAP (Switching Antiplatelet Therapy)-4 Study

Circulation (New York, N.Y.), 2018-06, Vol.137 (23), p.2450-2462

2018

Volltextzugriff (PDF)

Intramyocardial, Autologous CD34+ Cell Therapy for Refractory Angina

Circulation research, 2011-08, Vol.109 (4), p.428-436

2011

Volltextzugriff (PDF)

Platelet Function Profiles in Patients With Type 2 Diabetes and Coronary Artery Disease on Combined Aspirin and Clopidogrel Treatment

Diabetes (New York, N.Y.), 2005-08, Vol.54 (8), p.2430-2435

2005

Volltextzugriff (PDF)

Pharmacodynamic Profiles of Dual-Pathway Inhibition with or without Clopidogrel versus Dual Antiplatelet Therapy in Patients with Atherosclerotic Disease

Thrombosis and haemostasis, 2022-08, Vol.122 (8), p.1341-1351

2022

Volltextzugriff (PDF)

Randomized comparison of a high clopidogrel maintenance dose in patients with diabetes mellitus and coronary artery disease : Results of the optimizing antiplatelet therapy in diabetes mellitus (OPTIMUS) study

Circulation (New York, N.Y.), 2007-02, Vol.115 (6), p.708-716

2007

Volltextzugriff (PDF)

Pharmacodynamic and Pharmacokinetic Effects of a Low Maintenance Dose Ticagrelor Regimen Versus Standard Dose Clopidogrel in Diabetes Mellitus Patients Without Previous Major Cardiovascular Events Undergoing Elective Percutaneous Coronary Intervention: The OPTIMUS-6 Study

Circulation (New York, N.Y.), 2020-10, Vol.142 (15), p.1500-1502

2020

Volltextzugriff (PDF)

A head-to-head pharmacodynamic comparison of prasugrel vs. ticagrelor after switching from clopidogrel in patients with coronary artery disease: results of a prospective randomized study

European heart journal, 2016-09, Vol.37 (35), p.2722-2730

2016

Volltextzugriff (PDF)

Quantitative Magnetic Resonance Perfusion Imaging Detects Anatomic and Physiologic Coronary Artery Disease as Measured by Coronary Angiography and Fractional Flow Reserve

Journal of the American College of Cardiology, 2007-08, Vol.50 (6), p.514-522

2007

Volltextzugriff (PDF)

Effects of Edoxaban on the Cellular and Protein Phase of Coagulation in Patients with Coronary Artery Disease on Dual Antiplatelet Therapy with Aspirin and Clopidogrel: Results of the EDOX-APT Study

Thrombosis and haemostasis, 2020-01, Vol.120 (1), p.83-93

2020

Volltextzugriff (PDF)

Revascularization of Unprotected Left Main Coronary Artery Disease: Implications of Evolving Data on Clinical Practice

Circulation. Cardiovascular interventions, 2016-12, Vol.9 (12), p.e004782-e004782

2016

Volltextzugriff (PDF)

Effects of Methylnaltrexone on Ticagrelor-Induced Antiplatelet Effects in Coronary Artery Disease Patients Treated With Morphine

JACC. Cardiovascular interventions, 2019-08, Vol.12 (16), p.1538-1549

2019

Volltextzugriff (PDF)

Interventional Cardiology US Workforce: Current Challenges

Circulation. Cardiovascular interventions, 2014-12, Vol.7 (6), p.733-735

Bass, Theodore A

2014

Volltextzugriff (PDF)

1 – 25 von 320

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(302)
Mit Volltextzugriff
(297)

Publikationsform

2 weitere anzeigen...

Weniger anzeigen...

Sprache

Englisch
(318)
Japanisch
(24)
Spanisch
(3)
Deutsch
(1)

Erscheinungsjahr

n.n

Thema

Science & Technology
(159)
Life Sciences & Biomedicine
(157)
Humans
(155)
Cardiovascular System & Cardiology
(136)
Cardiac & Cardiovascular Systems
(122)
Male
(96)
Female
(89)
Middle Aged
(81)
Aged
(69)
Biological And Medical Sciences
(69)
Medical Sciences
(69)
Cardiovascular
(63)
Cardiology
(58)
Treatment Outcome
(53)
Cardiology. Vascular System
(43)
Prospective Studies
(41)
Internal Medicine
(40)
Ticlopidine - Analogs & Derivatives
(38)
Stents
(37)
Coronary Angiography
(31)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(2)

Menü

Weitere Dienste

Einstellungen

Percutaneous Coronary Interventions for Chronic Total Occlusions: As the Technology Expands, Our Responsibilities Increase

Platelet Inhibition With Cangrelor and Crushed Ticagrelor in Patients With ST-Segment–Elevation Myocardial Infarction Undergoing Primary Percutaneous Coronary Intervention: Results of the CANTIC Study

Variability in individual responsiveness to clopidogrel : Clinical implications, management, and future perspectives

High-Risk Percutaneous Coronary Interventions in Modern Day Clinical Practice: Current Concepts and Challenges

Percutaneous Coronary Intervention Versus Coronary Artery Bypass Graft Surgery in Left Main Coronary Artery Disease: A Meta-Analysis of Randomized Clinical Data

Pharmacodynamic Comparison of Prasugrel Versus Ticagrelor in Patients With Type 2 Diabetes Mellitus and Coronary Artery Disease: The OPTIMUS (Optimizing Antiplatelet Therapy in Diabetes Mellitus)-4 Study

The Challenges Involving Assessing Percutaneous Coronary Intervention Outcomes in Safety-Net Hospitals

Crushed Prasugrel Tablets in Patients With STEMI Undergoing Primary Percutaneous Coronary Intervention: The CRUSH Study

Impact of Stent Deployment Procedural Factors on Long-Term Effectiveness and Safety of Sirolimus-Eluting Stents (Final Results of the Multicenter Prospective STLLR Trial)

Impact of Chronic Kidney Disease on Platelet Function Profiles in Diabetes Mellitus Patients With Coronary Artery Disease Taking Dual Antiplatelet Therapy

Long-Term Outcomes in Patients Undergoing Coronary Stenting on Dual Oral Antiplatelet Treatment Requiring Oral Anticoagulant Therapy

Impact of Platelet Reactivity on Cardiovascular Outcomes in Patients With Type 2 Diabetes Mellitus and Coronary Artery Disease

Crushed Prasugrel Tablets in Patients With STEMI Undergoing Primary Percutaneous Coronary Intervention

Pharmacodynamic Effects of Switching From Ticagrelor to Clopidogrel in Patients With Coronary Artery Disease: Results of the SWAP (Switching Antiplatelet Therapy)-4 Study

Intramyocardial, Autologous CD34+ Cell Therapy for Refractory Angina

Platelet Function Profiles in Patients With Type 2 Diabetes and Coronary Artery Disease on Combined Aspirin and Clopidogrel Treatment

Pharmacodynamic Profiles of Dual-Pathway Inhibition with or without Clopidogrel versus Dual Antiplatelet Therapy in Patients with Atherosclerotic Disease

Randomized comparison of a high clopidogrel maintenance dose in patients with diabetes mellitus and coronary artery disease : Results of the optimizing antiplatelet therapy in diabetes mellitus (OPTIMUS) study

Pharmacodynamic and Pharmacokinetic Effects of a Low Maintenance Dose Ticagrelor Regimen Versus Standard Dose Clopidogrel in Diabetes Mellitus Patients Without Previous Major Cardiovascular Events Undergoing Elective Percutaneous Coronary Intervention: The OPTIMUS-6 Study

A head-to-head pharmacodynamic comparison of prasugrel vs. ticagrelor after switching from clopidogrel in patients with coronary artery disease: results of a prospective randomized study

Quantitative Magnetic Resonance Perfusion Imaging Detects Anatomic and Physiologic Coronary Artery Disease as Measured by Coronary Angiography and Fractional Flow Reserve

Effects of Edoxaban on the Cellular and Protein Phase of Coagulation in Patients with Coronary Artery Disease on Dual Antiplatelet Therapy with Aspirin and Clopidogrel: Results of the EDOX-APT Study

Revascularization of Unprotected Left Main Coronary Artery Disease: Implications of Evolving Data on Clinical Practice

Effects of Methylnaltrexone on Ticagrelor-Induced Antiplatelet Effects in Coronary Artery Disease Patients Treated With Morphine

Interventional Cardiology US Workforce: Current Challenges

Suchergebnisse filtern